Blood Stream Infection Testing Global Market Report 2025

Description

Bloodstream infection testing involves diagnostic methods used to detect and identify pathogens such as bacteria, fungi, or viruses in the blood that lead to infections. This process typically includes blood cultures and molecular assays to pinpoint the specific microorganism causing the infection. Accurate and timely detection is essential for the effective treatment and management of conditions such as sepsis and other severe infections.

The primary product categories in bloodstream infection testing include instruments, reagents and consumables, and software and services. Instruments used in bloodstream infection testing refer to the specialized equipment and devices designed to detect and analyze pathogens in blood samples, facilitating precise diagnosis and infection monitoring. Testing is performed on samples such as whole blood or blood cultures, employing technologies such as polymerase chain reaction (PCR), mass spectrometry, in situ hybridization, and others. The end-users of this testing include hospitals and diagnostic centers, laboratory service providers, academic and research institutions, and more.

The blood stream infection testing market research report is one of a series of new reports from The Business Research Company that provides blood stream infection testing market statistics, including blood stream infection testing industry global market size, regional shares, competitors with a blood stream infection testing market share, detailed blood stream infection testing market segments, market trends and opportunities, and any further data you may need to thrive in the blood stream infection testing industry. This blood stream infection testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The blood stream infection testing market size has grown rapidly in recent years. It will grow from $7.59 billion in 2024 to $8.49 billion in 2025 at a compound annual growth rate (CAGR) of 11.9%. The growth in the historic period can be attributed to the rising incidence of hospital-acquired infections, growing prevalence of antimicrobial resistance, increasing aging population, increasing healthcare expenditure, and rising prevalence of chronic diseases.

The blood stream infection testing market size is expected to see rapid growth in the next few years. It will grow to $13.19 billion in 2029 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be attributed to increasing demand for rapid diagnostic tests, growing adoption of molecular diagnostics, rising focus on personalized medicine, government initiatives for infection control, and rising prevalence of multi-drug-resistant pathogens. Major trends in the forecast period include the growing use of AI in diagnostic tools, integration of telemedicine with diagnostic services, rising demand for home-based testing kits, development of multiplex diagnostic platforms, and growing partnerships between diagnostic companies and hospitals.

The rising prevalence of infectious diseases is projected to drive the growth of the bloodstream infection testing market in the future. Infectious diseases are defined as illnesses caused by pathogenic microorganisms, including bacteria, viruses, fungi, or parasites. The rates of infectious diseases are increasing due to several factors, such as heightened global travel, urbanization, climate change, antibiotic resistance, and gaps in vaccination coverage. Testing for bloodstream infections is crucial in diagnosing and identifying pathogens responsible for sepsis and other severe infections, enabling targeted and effective treatment. For example, in December 2023, the latest World Malaria Report published by the World Health Organization (WHO), a Switzerland-based United Nations agency, indicated that there were 249 million cases of malaria in 2022, up from 244 million cases in 2021. The estimated number of malaria-related deaths was 608,000 in 2022, compared to 610,000 in 2021. Thus, the increasing prevalence of infectious diseases is driving the bloodstream infection testing market.

Key companies in the bloodstream infection testing market are focusing on product innovation to maintain their market position, particularly by developing blood testing cartridges. These disposable devices are designed to analyze blood samples during diagnostic tests, containing preloaded reagents and integrated sensors or microfluidic channels that help detect specific biomarkers, pathogens, or conditions from a small blood sample. For instance, in August 2022, Immunexpress Pty Ltd., an Australian molecular diagnostics company, introduced SeptiCyte RAPID cartridges. These cartridges utilize undiluted ethylenediaminetetraacetic acid (EDTA) blood as a validated sample type, showing a strong correlation with other blood collection methods in a multi-site European study. This innovation enhances the accuracy and speed of sepsis diagnosis, promoting broader clinical use and potentially transforming patient care while reducing healthcare costs.

In January 2023, Thermo Fisher Scientific Inc., a U.S.-based life science and clinical research company, acquired Binding Site Group Ltd. for $2.8 billion. The acquisition aims to strengthen Thermo Fisher's specialty diagnostics segment by incorporating Binding Site's innovative technologies for diagnosing and monitoring multiple myeloma, enhancing clinical value, accelerating patient outcomes, and contributing to the growth of the diagnostics market. Binding Site Group Ltd., based in the UK, manufactures medical diagnostic products focused on detecting cancer and immune disorders.

Major companies operating in the blood stream infection testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd, Danaher Corporation, Siemens Healthcare Private Limited, Becton Dickinson and Company (BD), Grifols S.A., Hologic Inc., BIOMERIEUX SA, Bio-Rad Laboratories Inc., Bruker Corporation, Qiagen N.V., DiaSorin S.p.A., Seegene Inc., Cepheid, Meridian Bioscience Inc., Biocartis NV, T2 Biosystems Inc., Molzym GmbH & Co. KG, Curetis GmbH, Accelerate Diagnostics Inc., OpGen Inc.

North America was the largest region in the blood stream infection testing market in 2024. The regions covered in the blood stream infection testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the blood stream infection testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The blood stream infection testing market consists of revenues earned by entities by providing services such as molecular diagnostics, serological assays, rapid diagnostic tests, next-generation sequencing, and pathogen identification and sensitivity testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The blood stream infection testing market also includes sales of blood culture media, molecular diagnostics kits, rapid diagnostic tests, automated blood culture systems, microbial identification panels, sepsis biomarker assays, and immunoassay kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Blood Stream Infection Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on blood stream infection testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for blood stream infection testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The blood stream infection testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product Type: Instruments; Reagents And Consumables; Software And Services
2) By Sample Type: Whole Blood; Blood Culture
3) By Technology: Polymerase Chain Reaction (PCR); Mass Spectroscopy; In Situ Hybridization; Other Technologies
4) By End-User: Hospitals And Diagnostic Centers; Laboratory Service Providers; Academic And Research Institutes; Other End-Users
Subsegments:
1) By Instruments: Blood Culture Systems; Automated Microbial Identification Systems; Molecular Diagnostic Instruments
2) By Reagents and Consumables: Blood Culture Media; Antimicrobial Susceptibility Testing Reagents; Nucleic Acid Extraction Kits
3) By Software and Services: Laboratory Information Management Systems (LIMS); Data Analysis Software; Maintenance And Support Services
Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Laboratories; F. Hoffmann-La Roche Ltd; Danaher Corporation; Siemens Healthcare Private Limited
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r33444

1. Executive Summary

2. Blood Stream Infection Testing Market Characteristics

3. Blood Stream Infection Testing Market Trends And Strategies

4. Blood Stream Infection Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Blood Stream Infection Testing Growth Analysis And Strategic Analysis Framework

5.1. Global Blood Stream Infection Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Blood Stream Infection Testing Market Growth Rate Analysis
5.4. Global Blood Stream Infection Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Blood Stream Infection Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Blood Stream Infection Testing Total Addressable Market (TAM)

6. Blood Stream Infection Testing Market Segmentation

6.1. Global Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Instruments
Reagents And Consumables
Software And Services
6.2. Global Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Whole Blood
Blood Culture
6.3. Global Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Polymerase Chain Reaction (PCR)
Mass Spectroscopy
In Situ Hybridization
Other Technologies
6.4. Global Blood Stream Infection Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Diagnostic Centers
Laboratory Service Providers
Academic And Research Institutes
Other End-Users
6.5. Global Blood Stream Infection Testing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Blood Culture Systems
Automated Microbial Identification Systems
Molecular Diagnostic Instruments
6.6. Global Blood Stream Infection Testing Market, Sub-Segmentation Of Reagents and Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Blood Culture Media
Antimicrobial Susceptibility Testing Reagents
Nucleic Acid Extraction Kits
6.7. Global Blood Stream Infection Testing Market, Sub-Segmentation Of Software and Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Laboratory Information Management Systems (LIMS)
Data Analysis Software
Maintenance And Support Services

7. Blood Stream Infection Testing Market Regional And Country Analysis

7.1. Global Blood Stream Infection Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Blood Stream Infection Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Blood Stream Infection Testing Market

8.1. Asia-Pacific Blood Stream Infection Testing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Blood Stream Infection Testing Market

9.1. China Blood Stream Infection Testing Market Overview
9.2. China Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Blood Stream Infection Testing Market

10.1. India Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Blood Stream Infection Testing Market

11.1. Japan Blood Stream Infection Testing Market Overview
11.2. Japan Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Blood Stream Infection Testing Market

12.1. Australia Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Blood Stream Infection Testing Market

13.1. Indonesia Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Blood Stream Infection Testing Market

14.1. South Korea Blood Stream Infection Testing Market Overview
14.2. South Korea Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Blood Stream Infection Testing Market

15.1. Western Europe Blood Stream Infection Testing Market Overview
15.2. Western Europe Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Blood Stream Infection Testing Market

16.1. UK Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Blood Stream Infection Testing Market

17.1. Germany Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Blood Stream Infection Testing Market

18.1. France Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Blood Stream Infection Testing Market

19.1. Italy Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Blood Stream Infection Testing Market

20.1. Spain Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Blood Stream Infection Testing Market

21.1. Eastern Europe Blood Stream Infection Testing Market Overview
21.2. Eastern Europe Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Blood Stream Infection Testing Market

22.1. Russia Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Blood Stream Infection Testing Market

23.1. North America Blood Stream Infection Testing Market Overview
23.2. North America Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Blood Stream Infection Testing Market

24.1. USA Blood Stream Infection Testing Market Overview
24.2. USA Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Blood Stream Infection Testing Market

25.1. Canada Blood Stream Infection Testing Market Overview
25.2. Canada Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Blood Stream Infection Testing Market

26.1. South America Blood Stream Infection Testing Market Overview
26.2. South America Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Blood Stream Infection Testing Market

27.1. Brazil Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Blood Stream Infection Testing Market

28.1. Middle East Blood Stream Infection Testing Market Overview
28.2. Middle East Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Blood Stream Infection Testing Market

29.1. Africa Blood Stream Infection Testing Market Overview
29.2. Africa Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Blood Stream Infection Testing Market Competitive Landscape And Company Profiles

30.1. Blood Stream Infection Testing Market Competitive Landscape
30.2. Blood Stream Infection Testing Market Company Profiles
- 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Siemens Healthcare Private Limited Overview, Products and Services, Strategy and Financial Analysis

31. Blood Stream Infection Testing Market Other Major And Innovative Companies

31.1. Becton Dickinson and Company (BD)
31.2. Grifols S.A.
31.3. Hologic Inc.
31.4. BIOMERIEUX SA
31.5. Bio-Rad Laboratories Inc.
31.6. Bruker Corporation
31.7. Qiagen N.V.
31.8. DiaSorin S.p.A.
31.9. Seegene Inc.
31.10. Cepheid
31.11. Meridian Bioscience Inc.
31.12. Biocartis NV
31.13. T2 Biosystems Inc.
31.14. Molzym GmbH & Co. KG
31.15. Curetis GmbH

32. Global Blood Stream Infection Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Blood Stream Infection Testing Market

34. Recent Developments In The Blood Stream Infection Testing Market

35. Blood Stream Infection Testing Market High Potential Countries, Segments and Strategies

35.1 Blood Stream Infection Testing Market In 2029 - Countries Offering Most New Opportunities
35.2 Blood Stream Infection Testing Market In 2029 - Segments Offering Most New Opportunities
35.3 Blood Stream Infection Testing Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
250423_r33444_Blood_Stream_Infection_Testing_GMR_2025